Safety and immtunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthethic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa

Sirima, SB; Nebie, I; Ouedraogo, A; Tiono, AB; Konate, AT; Gansane, A; Derme, AI; Diarra, A; Ouedraogo, A; Soulama, I; +3 more... Cuzzin-Ouattara, N; Cousens, S; Leroy, O; (2007) Safety and immtunogenicity of the Plasmodium falciparum merozoite surface protein-3 long synthethic peptide (MSP3-LSP) malaria vaccine in healthy, semi-immune adult males in Burkina Faso, West Africa. Vaccine, 25 (14). pp. 2723-2732. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2006.05.090

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.vaccine.2006.05.090

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar